Microbiota and metabolomic profiling coupled with machine learning to identify biomarkers and drug targets in nasopharyngeal carcinoma
Our findings highlight the interplay between microbiota and metabolite profiles in influencing radiotherapy outcomes in NPC. These results suggest that targeting the microbiota-metabolite axis may enhance radiotherapy efficacy in NPC.
Authors
- Junsong Liu (ORCID: https://orcid.org/0000-0003-4954-1783)
- Jianhua Huang (ORCID: https://orcid.org/0000-0001-6509-1765)
- Rui Wang
- Ruimin Zhao
- Chongwen Xu (ORCID: https://orcid.org/0000-0002-4147-0397)
Institutions
- First Affiliated Hospital of Xi'an Jiaotong University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-02-26
- DOI
- https://doi.org/10.3389/fphar.2025.1551411
- Citations
- 2
- Primary Topic
- Metabolomics and Mass Spectrometry Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.61